Taurine as an adjunct therapy for early left ventricular recovery in peripartum cardiomyopathy

IF 0.2 Q4 ANESTHESIOLOGY
H. Zaki, M. Sweed, Rania M. Ali, M. Abdelhafeez
{"title":"Taurine as an adjunct therapy for early left ventricular recovery in peripartum cardiomyopathy","authors":"H. Zaki, M. Sweed, Rania M. Ali, M. Abdelhafeez","doi":"10.4103/joacc.JOACC_36_20","DOIUrl":null,"url":null,"abstract":"Background and Aims: The pathophysiology of peripartum cardiomyopathy is not fully understood. Despite standard medical therapy, both morbidity and mortality remain high. Restoration of inflammatory cytokine balance may hold promise for therapy. Taurine has a powerful immune-modulatory and anti-inflammatory in addition to positive inotropic effect. This study evaluates the effect of taurine infusion on clinical status, left ventricular function, circulating plasma levels of N-terminal brain natriuretic peptide and C-reactive protein in women with peripartum cardiomyopathy. Methods: Forty women with peripartum cardiomyopathy admitted postpartum to the ICU were randomly assigned to one of two groups (20 in each group): Group T received taurine infusion and Group C received normal saline infusion over 24 hours for 5 days. Both groups received standard heart failure therapy according the institutional treatment protocol. Results: In the taurine group on day 5, there was a significant reduction in LVEDD and LVESD and significant increase in LVEF. All patients had an improvement in LVEF of at least 10% and 5 patients had recovery of LVEF to ≥50% on day 5 while the other 15 patients had LVEF 45- 50%. In the control group on day 5, there was non-significant change in LVEDD, LVESD and LVEF and no patient had recovery of LVEF to ≥50% or showed improvement in LVEF more than 10%. NYHA functional class showed significant increase on day 5 in the taurine group compared to the control group. Seventeen patients (85%) in the taurine group showed improvement of the NYHA functional class at day 5. In contrast, only 2 patients (10%) in the control group showed improvement of NYHA functional class at day 5. Conclusion: Early addition of taurine infusion to standard heart failure therapy improves both; echocardiographic parameters and laboratory parameters but without clinically significant changes in women with peripartum cardiomyopathy.","PeriodicalId":16611,"journal":{"name":"Journal of Obstetric Anaesthesia and Critical Care","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obstetric Anaesthesia and Critical Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/joacc.JOACC_36_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Background and Aims: The pathophysiology of peripartum cardiomyopathy is not fully understood. Despite standard medical therapy, both morbidity and mortality remain high. Restoration of inflammatory cytokine balance may hold promise for therapy. Taurine has a powerful immune-modulatory and anti-inflammatory in addition to positive inotropic effect. This study evaluates the effect of taurine infusion on clinical status, left ventricular function, circulating plasma levels of N-terminal brain natriuretic peptide and C-reactive protein in women with peripartum cardiomyopathy. Methods: Forty women with peripartum cardiomyopathy admitted postpartum to the ICU were randomly assigned to one of two groups (20 in each group): Group T received taurine infusion and Group C received normal saline infusion over 24 hours for 5 days. Both groups received standard heart failure therapy according the institutional treatment protocol. Results: In the taurine group on day 5, there was a significant reduction in LVEDD and LVESD and significant increase in LVEF. All patients had an improvement in LVEF of at least 10% and 5 patients had recovery of LVEF to ≥50% on day 5 while the other 15 patients had LVEF 45- 50%. In the control group on day 5, there was non-significant change in LVEDD, LVESD and LVEF and no patient had recovery of LVEF to ≥50% or showed improvement in LVEF more than 10%. NYHA functional class showed significant increase on day 5 in the taurine group compared to the control group. Seventeen patients (85%) in the taurine group showed improvement of the NYHA functional class at day 5. In contrast, only 2 patients (10%) in the control group showed improvement of NYHA functional class at day 5. Conclusion: Early addition of taurine infusion to standard heart failure therapy improves both; echocardiographic parameters and laboratory parameters but without clinically significant changes in women with peripartum cardiomyopathy.
牛磺酸辅助治疗围产期心肌病早期左心室恢复
背景与目的:围产期心肌病的病理生理机制尚不完全清楚。尽管有标准的药物治疗,发病率和死亡率仍然很高。恢复炎症细胞因子平衡可能为治疗带来希望。牛磺酸除了积极的肌力作用外,还具有强大的免疫调节和抗炎作用。本研究评价牛磺酸输注对围产期心肌病妇女临床状态、左心室功能、循环血浆n端脑钠肽和c反应蛋白水平的影响。方法:将40例产后入住ICU的围产期心肌病患者随机分为两组(每组20例):T组给予牛磺酸输注,C组给予生理盐水输注,持续5 d,持续24 h。两组患者均根据机构治疗方案接受标准心力衰竭治疗。结果:第5天牛磺酸组LVEDD、LVESD显著降低,LVEF显著升高。所有患者的LVEF至少改善10%,5例患者在第5天LVEF恢复到≥50%,其他15例患者的LVEF为45- 50%。对照组患者第5天LVEDD、LVESD和LVEF均无显著变化,无患者LVEF恢复≥50%或LVEF改善超过10%。与对照组相比,牛磺酸组的NYHA功能等级在第5天显着增加。牛磺酸组17例(85%)患者在第5天NYHA功能等级有所改善。相比之下,对照组只有2例(10%)患者在第5天NYHA功能等级改善。结论:在标准心力衰竭治疗中早期加入牛磺酸输注对两者均有改善;围产期心肌病妇女超声心动图参数和实验室参数无临床显著变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
37
审稿时长
29 weeks
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信